Browsing byAuthorSchulz, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 35 to 41 of 41< previous 
Issue DateTitleAuthor(s)
2022-08-06Task sharing in an interprofessional medication management program - a survey of general practitioners and community pharmacists.Moecker, R; Weissenborn, M; Klingenberg, A; Wirbka, L; Fuchs, A; Eickhoff, C; Mueller, U; Schulz, M; Kaufmann-Kolle, P; ARMIN Study Group,; Haefeli, WE; Seidling, HM
2022-03The AMULET ménage à trois: nurse, telemedicine support, and remote cardiologist.Koehler, F; Schulz, M
2020-03The frequency of photosensitizing drug dispensings in Austria and Germany: a correlation with their photosensitizing potential based on published literature.Hofmann, GA; Gradl, G; Schulz, M; Haidinger, G; Tanew, A; Weber, B
2020-07-23The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial.Schulz, M; Griese-Mammen, N; Schumacher, PM; Anker, SD; Koehler, F; Ruckes, C; Rettig-Ewen, V; Wachter, R; Trenk, D; Böhm, M; Laufs, U
2022Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012-2021.Katzmann, JL; Kieble, M; Enners, S; Böhm, M; Mahfoud, F; Laufs, U; Schulz, M
2022-02-27Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia.Mahfoud, F; Kieble, M; Enners, S; Kintscher, U; Laufs, U; Böhm, M; Schulz, M
2021-11Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave.Enners, S; Gradl, G; Kieble, M; Böhm, M; Laufs, U; Schulz, M